Pharma Pulse: Shionogi's $2.5B Radicava Acquisition and the Industry Monitors U.S.-Iran Conflict for Supply Disruptions

In today’s Pharma Pulse, Shionogi acquires global rights to the ALS treatment Radicava, and experts monitor drug supply chains as the U.S.-Iran conflict drives up logistics costs.